TherapeuticsMD
TXMD
TXMD
123 hedge funds and large institutions have $1.36B invested in TherapeuticsMD in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 128 → 123 (-5)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Holders
123
Holding in Top 10
1
Calls
$4.97M
Puts
$1.14M
Top Buyers
| 1 | +$28.1M | |
| 2 | +$25.5M | |
| 3 | +$25.1M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.3M |
Top Sellers
| 1 | -$27M | |
| 2 | -$6.34M | |
| 3 | -$3.8M | |
| 4 |
GH
GAM Holding
Zurich,
Switzerland
|
-$3.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.55M |